Did your doctor get COVID? new study checks antibodies in primary care workers
NCT ID NCT04808986
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study tested nearly 2,800 primary care health workers (like doctors, pharmacists, and dentists) and their household members in France for COVID-19 antibodies. The goal was to find out how many had been exposed to the virus and to understand risk factors. Participants used a simple finger-prick blood test at home and mailed it in for analysis.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help public health officials better understand how many primary care workers and their families were exposed to COVID-19, guiding future vaccination and safety protocols.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures past exposure, not protection from future infection. Results may not apply to other regions or time periods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
2,817 people
The number who actually took part.
- Started
-
May 2021
- Finished
-
Oct 2021
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Health professionals in primary care : * General practitioners, paediatricians, pharmacists, pharmacy assistants, dental surgeons or dental assistants practising in metropolitan France at the time of inclusion (condition ensured by affiliation to one of the four networks); * Be affiliated to one of the following networks: Sentinelles, AFPA, IQVIA, ReCOL or work in a city pharmacy (for pharmacy assistants) or in a dental practice (dental assistants) whose owners are affiliated to these networks; * To be a volunteer to participate in the study; * To have given their agreement in principle to the collection of data (including personal data) necessary for recruitment; * Have given their consent to participate in the study; * To be affiliated to a social security scheme or to be a beneficiary of such a scheme. Members of health professionals' households : * Occupy the same dwelling as a healthcare professional included in PHASE 1 of the COVID-SeroPRIM study at least 2 days per week (including weekend attendees, every other week, etc.) at the time of inclusion in the study, without necessarily being related; * To have volunteered to participate in the study; * To have given their consent to participate in the study or, in the case of minors, consent given by the representative(s) of the parental authority; * To be able to understand the study process, to fill in the questionnaires and to take the planned samples (if the person included is old enough to understand). Exclusion criteria : * Persons subject to a legal protection measure (safeguard of justice, curatorship, guardianship); * Persons who have participated in clinical trials to test chemoprophylaxis to prevent infection with SARS-CoV-2. * Minors who do not have a parent or guardian in the health professional's household
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Pierre Louis Epidemiologie Et Sante Publique
Paris, 75012, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home antibody tests put to the test: can you read your own COVID-19 result?
- COVID-19's hidden toll: muscle wasting in the ICU
- Can a mild case of COVID-19 harm your kidneys? urine tests may hold the answer
- Could a common acne pill weaken the nose's defense against COVID-19?
- Could cystic fibrosis offer hidden protection against COVID-19?
- Could a different way of pedaling rebuild muscles after severe COVID-19?